| Kelly L Crenshaw, PSYD | |
|
12 Bellwether Way Ste 240, Bellingham, WA 98225-2959 | |
| (360) 588-2500 | |
| (360) 785-2016 |
| Full Name | Kelly L Crenshaw |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 12 Years |
| Location | 12 Bellwether Way Ste 240, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649694662 | NPI | - | NPPES |
| PY60885078 | Other | WA | DEPARTMENT OF HEALTH |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascade Neuropsychology, Pllc | 2961767512 | 3 |
News Archive
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer's in laboratory studies.
Findings by scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna reveal a surprising role for histone deacetylase 1 (HDAC1) - a member of a family of chromatin modifying proteins - in the development of skin tumors.
CSIRO, Australia's national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including 'long-COVID'.
EDGE Medical Devices today announced that New York Imaging Service has become an authorized distributor of the Quix™ Plasma DR™ digital detector and Universal Retrofit Kit.
Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) solar energy production, (ii) medical diagnostics and sensors and (iii) biotechnology research and development tools, today announced that Dr. Michelle Khine, Ph.D., the scientific founder of Shrink's nanofabrication platform, was named by MIT Technology Review as one of the top 35 global innovators under the age of 35.
› Verified 7 days ago
| Entity Name | Cascade Neuropsychology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871099937 PECOS PAC ID: 2961767512 Enrollment ID: O20201229001925 |
News Archive
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer's in laboratory studies.
Findings by scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna reveal a surprising role for histone deacetylase 1 (HDAC1) - a member of a family of chromatin modifying proteins - in the development of skin tumors.
CSIRO, Australia's national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including 'long-COVID'.
EDGE Medical Devices today announced that New York Imaging Service has become an authorized distributor of the Quix™ Plasma DR™ digital detector and Universal Retrofit Kit.
Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) solar energy production, (ii) medical diagnostics and sensors and (iii) biotechnology research and development tools, today announced that Dr. Michelle Khine, Ph.D., the scientific founder of Shrink's nanofabrication platform, was named by MIT Technology Review as one of the top 35 global innovators under the age of 35.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly L Crenshaw, PSYD 12 Bellwether Way Ste 240, Bellingham, WA 98225-2959 Ph: (360) 588-2500 | Kelly L Crenshaw, PSYD 12 Bellwether Way Ste 240, Bellingham, WA 98225-2959 Ph: (360) 588-2500 |
News Archive
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer's in laboratory studies.
Findings by scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna reveal a surprising role for histone deacetylase 1 (HDAC1) - a member of a family of chromatin modifying proteins - in the development of skin tumors.
CSIRO, Australia's national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including 'long-COVID'.
EDGE Medical Devices today announced that New York Imaging Service has become an authorized distributor of the Quix™ Plasma DR™ digital detector and Universal Retrofit Kit.
Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) solar energy production, (ii) medical diagnostics and sensors and (iii) biotechnology research and development tools, today announced that Dr. Michelle Khine, Ph.D., the scientific founder of Shrink's nanofabrication platform, was named by MIT Technology Review as one of the top 35 global innovators under the age of 35.
› Verified 7 days ago